XML 334 R55.htm IDEA: XBRL DOCUMENT v3.25.0.1
Capital Stock (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2024
Mar. 31, 2024
Schedule of Share-Based Compensation Expense
The Company recognized the following share-based compensation expense during the three and nine months ended December 31, 2024 and 2023:
 
Three Months Ended
December 31,
Nine Months Ended
December 31,
  2024  
  2023  
  2024  
  2023  
(Amounts in millions)
Compensation Expense:
           
Stock options
  
$
0.2
    
$
0.4
    
$
0.6
    
$
1.4
 
Restricted share units and other share-based compensation
    
13.9
      
12.2
      
30.3
      
32.6
 
Share appreciation rights
    
0.2
      
0.1
      
0.5
      
0.2
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Lionsgate Studios employee share-based compensation expense
    
14.3
      
12.7
      
31.4
      
34.2
 
Corporate allocation of share-based compensation
    
      
4.5
      
10.8
      
12.1
 
  
 
 
    
 
 
    
 
 
    
 
 
 
    
14.3
      
17.2
      
42.2
      
46.3
 
Impact of accelerated vesting on equity awards
(1)
    
      
6.8
      
4.7
      
7.3
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total share-based compensation expense
  
$
14.3
    
$
24.0
    
$
46.9
    
$
53.6
 
  
 
 
    
 
 
    
 
 
    
 
 
 

(1)
Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements prior to the Separation.
Share-based compensation expense, by expense category, consisted of the following:
 
Three Months Ended
December 31,
Nine Months Ended
December 31,
  2024  
  2023  
  2024  
  2023  
(Amounts in millions)
Share-Based Compensation Expense:
           
General and administration
  
$
14.3
    
$
17.2
    
$
42.2
    
$
46.3
 
Restructuring and other
    
— 
      
6.8
      
4.7
      
7.3
 
  
 
 
    
 
 
    
 
 
    
 
 
 
  
$
14.3
    
$
24.0
    
$
46.9
    
$
53.6
 
  
 
 
    
 
 
    
 
 
    
 
 
 
The Company recognized the following share-based compensation expense during the years ended March 31, 2024, 2023 and 2022:
 
    
Year Ended March 31,
 
    
2024
    
2023
    
2022
 
    
(Amounts in millions)
 
Compensation Expense:
        
Stock options
   $ 1.7      $ 2.3      $ 9.6  
Restricted share units and other share-based compensation
     37.7        39.3        38.6  
Share appreciation rights
     0.4        0.9        2.4  
  
 
 
    
 
 
    
 
 
 
Total Studio employee share-based compensation expense
     39.8        42.5        50.6  
Corporate allocation of share-based compensation
     15.0        26.7        19.6  
  
 
 
    
 
 
    
 
 
 
     54.8        69.2        70.2  
Impact of accelerated vesting on equity awards
(1)
     7.7        4.2        —   
  
 
 
    
 
 
    
 
 
 
Total share-based compensation expense
     62.5        73.4        70.2  
Tax impact
(2)
     (15.1      (17.8      (16.7
  
 
 
    
 
 
    
 
 
 
Reduction in net income
   $ 47.4      $ 55.6      $ 53.5  
  
 
 
    
 
 
    
 
 
 
 
(1)
Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements.
(2)
Represents the income tax benefit recognized in the statements of operations for share-based compensation arrangements prior to the effects of changes in the valuation allowance.
Schedule of Stock Option, SARs, Restricted Stock and Restricted Share Unit Activity
The following table sets forth the stock option, share appreciation rights (“SARs”), restricted stock and restricted share unit activity at Lionsgate for grants related directly to the Company employees and Lionsgate corporate and shared service employees during the nine months ended December 31, 2024:
 
Stock Options and SARs
Restricted Stock and Restricted Share Units
Lions Gate Class A
Voting Shares
Lions Gate Class B
Non-Voting
Shares
Lions Gate Class A
Voting Shares
Lions Gate Class B
Non-Voting
Shares
Number
of
Shares
Weighted-
Average
Exercise
Price
Number
of
Shares
Weighted-
Average
Exercise
Price
Number
of
Shares
Weighted-
Average
Grant-
Date Fair
Value
Number
of
Shares
Weighted-
Average
Grant-Date

Fair Value
(Number of shares in millions)
Outstanding at March 31, 2024
    
2.4
   
$
22.96
      
17.1
   
$
13.92
      
0.1
   
$
9.27
      
9.8
   
$
8.93
 
Granted
    
     
      
(1)
 
 
$
7.12
      
0.1
   
$
8.20
      
8.1
   
$
7.98
 
Options exercised or restricted stock or RSUs vested
    
     
      
(0.1
)
 
$
5.50
      
(0.1
)
 
$
9.20
      
(5.8
)
 
 
$
8.79
 
Forfeited or expired
    
(0.1
)
 
 
$
20.26
      
(2.2
)
 
$
14.64
      
     
      
(0.6
)
 
$
8.52
 
  
 
 
   
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
   
 
 
 
Outstanding at December 31, 2024
    
2.3
   
$
23.10
      
14.8
   
$
13.86
      
0.1
   
$
8.39
      
11.5
   
$
8.20
 
  
 
 
   
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
   
 
 
 

(1)
Represents less than 0.1 million shares.